Why Sonoma Pharmaceuticals (SNOA) Stock Is Moving
Why Sonoma Pharmaceuticals (SNOA) Stock Is Moving
Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) shares are trading lower by 11.9% to $0.19 Wednesday morning after the company announced a 1-for-20 reverse stock split.
Sonoma Pharmaceuticals公司（納斯達克代碼：SNOA）的股票在週三上午以11.9%的跌幅交易至0.19美元，因公司宣佈進行1股對20股的股票逆向拆分。
The stock will trade on a split-adjusted basis starting August 30, 2024. This move aims to meet Nasdaq's $1.00 minimum bid price requirement. As a result, every 20 shares of Sonoma's common stock will be consolidated into one share, reducing the total outstanding shares from 20 million to 1 million.
從2024年8月30日開始，該股票將以拆分調整後的價位進行交易。此舉旨在滿足納斯達克的1.00美元最低買盤價格要求。因此，Sonoma的每20股普通股將合併爲1股，將總髮行股份從2000萬股減少至100萬股。
No fractional shares will be issued; instead, shareholders will receive cash for any fractions. The authorized shares will also increase from 24 million to 50 million.
不會發行碎股；相反，股東將獲得碎股的現金補償。授權股份也將從2400萬股增加至5000萬股。
Read Also: Will Nvidia Continue To Deliver? Investors Sweat Over Hyped-up Expectations And Potential Blackwell Delay Ahead Of Q2 Report
讀下文：英偉達是否將會繼續交付？投資者爲誇大預期和潛在的Blackwell延遲在Q2報告之前感到不安。
Should I Sell My SNOA Stock?
我應該賣出我的SNOA股票嗎？
Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.
賣出或持有股票很大程度上取決於投資者的策略和風險承受能力。短期交易者可能會出售表現優異的股票以鎖定資本收益，而長期投資者可能會在期待股價進一步增長的動盪中保持持有。
Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.
同樣，願意將損失最小化的交易者可能會出售下跌一定百分比的股票，而長期投資者則可能會將其視爲以折扣價買入更多股票的機會。
Shares of Sonoma Pharmaceuticals have lost 75.9% year to date. This compares to the average annual return of -66.61%, meaning the stock has underperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity.
Sonoma Pharmaceuticals的股票今年累計下跌75.9%，而平均年回報率爲-66.61%，這意味着該股票表現低於其歷史平均水平。投資者可以將一支股票的走勢與其歷史表現進行比較，以判斷此次波動是正常的還是潛在的交易機會。
For analysis tools, charting data and access to exclusive stock news, check out Benzinga PRO. Try it for free.
欲獲取分析工具、圖表數據和獨家股票新聞，請登錄Benzinga PRO。現在免費試用。
SNOA has a 52-week high of $1.02 and a 52-week low of $0.12.
SNOA的52周最高價爲$1.02，52周最低價爲$0.12。
譯文內容由第三人軟體翻譯。